Drug intelligence / Profile preview

dexamethasone

Development stage
Approved
Lead developer
Merck
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Dexamethasone is a long-acting synthetic corticosteroid with negligible mineralocorticoid activity. It is fluorinated at position 9 and is approximately 25 times more potent than hydrocortisone. Dexamethasone acts by binding to the glucocorticoid receptor inside cells, leading to changes in gene expression that suppress pro-inflammatory mediators (such as eosinophils, mast cells, macrophages, interleukins) and upregulate anti-inflammatory mediators. This results in reduced synthesis of prostaglandins and leukotrienes and overall immunosuppression. Dexamethasone is used to treat a wide range of conditions including inflammatory disorders (such as arthritis and skin diseases), allergic reactions, certain cancers (like multiple myeloma), adrenal insufficiency, severe allergies or asthma attacks, ulcerative colitis flare-ups, nervous system disorders like multiple sclerosis exacerbations or myasthenia gravis crises. It can be administered orally or by injection[1][2][4][5][6].

Brand names
DecadronDexPak 6 DayTaperpakDexPak6 DayTaperpakDexPak-6 DayTaperpakHemadyDexablissTaperDex
Other names
DEXAMETHASONE 21-VALERATEDEXAMETHASONE21-VALERATEDEXAMETHASONE-21-VALERATEDEXAMETHASONE 21-PENTANOATEDEXAMETHASONE21-PENTANOATEDEXAMETHASONE-21-PENTANOATEPREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,17-DIHYDROXY-16-METHYL-21-((1-OXOPENTYL)OXY)-, (11.BETA.,16.ALPHA.)-PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.ALPHA.-METHYL-, 21-VALERATE
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call